The authors show that inhibition of the Smad pathway with LND-193189, a Smad signaling inhibitor, attenuates COL11A1-mediated increase of NSCLC proliferation, migration, invasion, and cisplatin resistance in vitro [47]. This evidence concerns the gene COL11A1 and non-small cell lung carcinoma.